ADARx Pharmaceuticals, Inc. (ADRX)
NASDAQ
Closed
Oct 19, 2026
Day's Range
17.0552 wk Range
16.64Overview - ADRX - ADARx Pharmaceuticals, Inc.
Key Statistics
Valuation
Enterprise Value
1.81B
Price / Sales (TTM)
‪307.66‬
EV / EBITDA
‪-17.29‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪-4,006.83%‬
Ownership
Shares Outstanding
106.80M
Float
43.84M
Held by Insiders
‪41.77%‬
Held by Institutions
‪29.56%‬
Price stats
50-Day Avg
‪18.63‬
200-Day Avg
‪18.63‬
Market Cap - ADRX - ADARx Pharmaceuticals, Inc.
Peers - ADRX - ADARx Pharmaceuticals, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- ADRXNASDAQADARx Pharmaceuticals, Inc.1.88BMarket Cap-9.63%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
- ARGXNASDAQArgenx SE51.51BMarket Cap-3.70%52-week change31.22P/E (Trailing)‪32.26%‬Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.31.02BMarket Cap-111.89%52-week change39.09P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNASDAQBioNTech SE American Depositary Share22.03BMarket Cap-23.08%52-week change160.80P/E (Trailing)‪-63.63%‬Profit Margin
- ASNDNASDAQAscendis Pharma A/S14.82BMarket Cap+8.90%52-week change17.26P/E (Trailing)‪70.84%‬Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.12.97BMarket Cap+15.27%52-week change-17.56P/E (Trailing)‪-97.02%‬Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.10.58BMarket Cap+1.57%52-week change147.76P/E (Trailing)‪2.14%‬Profit Margin
Profile Summary - ADRX - ADARx Pharmaceuticals, Inc.
About
ADARx Pharmaceuticals, Inc. is a late-stage biotechnology company focused on developing next-generation siRNA therapeutics. The company works on RNA interference-based medicines designed to silence disease-causing genes and address conditions with significant unmet medical needs. Its current pipeline includes…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
